
James M. Scheiman, MD
Advertisement
Articles by James M. Scheiman, MD
Advertisement
Latest Updated Articles
Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care PerspectivePublished: November 1st 2002 | Updated:
Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using CoxibsPublished: November 1st 2002 | Updated:
The Impact of Nonsteroidal Anti-Inflammatory Drug-Induces GastropathyPublished: February 1st 2001 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5



